Tamoxifen-associated skin reactions in breast cancer patients: from case report to literature review Peter AndrewSabira ValianiShailendra Verma Review 08 October 2014 Pages: 1 - 5
Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene Suzanne LamEliza WiercinskaAart G. Jochemsen Preclinical Study 26 September 2014 Pages: 7 - 18
Growth and metastatic behavior of molecularly well-characterized human breast cancer cell lines in mice Muhammad RiazBuddy Setyono-HanJohn W. M. Martens Preclinical study 30 September 2014 Pages: 19 - 31
Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients Mirjam E. MastEline J. VredeveldJohn H. Maduro Preclinical study Open access 01 October 2014 Pages: 33 - 39
Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome Katherine Drews-ElgerElizabeth IornsMarc E. Lippman Preclinical Study 01 October 2014 Pages: 41 - 59
Pigment epithelium-derived factor (PEDF) inhibits breast cancer metastasis by down-regulating fibronectin Honghai HongTi ZhouGuoquan Gao Preclinical study 05 October 2014 Pages: 61 - 72
Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series Luigi Di LauroPatrizia ViciMarcello Maugeri-Saccà Clinical trial 20 September 2014 Pages: 73 - 80
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial Andrea DeCensiMatteo PuntoniMichael N. Pollak Clinical trial Open access 25 September 2014 Pages: 81 - 90
Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients So-Youn JungKyung Hwan ShinJungsil Ro Clinical trial 25 September 2014 Pages: 91 - 98
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007 Kathy D. MillerSandra K. AlthousePatricia S. Steeg Clinical trial 26 September 2014 Pages: 99 - 106
A randomized, double-blind, active control, multicenter, dose-finding study of lipegfilgrastim (XM22) in breast cancer patients receiving myelosuppressive therapy Anton BuchnerReiner ElsässerPeter Bias Clinical trial Open access 27 September 2014 Pages: 107 - 116
Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers? Monica Maria YepesAda Pat RomillyStefan Glück Clinical Trial 28 September 2014 Pages: 117 - 123
Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center Mehra GolshanKatya LoskCraig Bunnell Clinical trial 01 October 2014 Pages: 125 - 133
No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen Tom Wei-Wu ChenHo-Min ChenYen-Shen Lu Epidemiology 21 September 2014 Pages: 135 - 142
Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies Jessica SalmenJulia NeugebauerBrigitte Rack Epidemiology 25 September 2014 Pages: 143 - 151
Diabetes, diabetes treatment and breast cancer prognosis Juhua LuoBeth VirnigKaren Margolis Epidemiology 27 September 2014 Pages: 153 - 162
Racial disparities in risk of second breast tumors after ductal carcinoma in situ Ying LiuGraham A. ColditzMelody Goodman Epidemiology 27 September 2014 Pages: 163 - 173
Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy Yinzhi LaiJuan P. PalazzoHushan Yang Epidemiology 27 September 2014 Pages: 175 - 185
Mammography interval and breast cancer mortality in women over the age of 75 Michael S. SimonSylvia Wassertheil-SmollerLew H. Kuller Epidemiology 25 September 2014 Pages: 187 - 195
Lapatinib-associated mucocutaneous toxicities are clinical predictors of improved progression-free survival in patients with human epidermal growth factor receptor (HER2)-positive advanced breast cancer Kazuhiro ArakiIppei FukadaYoshinori Ito Epidemiology 01 October 2014 Pages: 197 - 209
Dual specificity phosphatase 4 gene expression in association with triple-negative breast cancer outcome Michelle L. BagliaQiuyin CaiXiao-Ou Shu Epidemiology 04 October 2014 Pages: 211 - 220
Expression of regulators of mitotic fidelity are associated with intercellular heterogeneity and chromosomal instability in primary breast cancer Rebecca RoylanceDavid EndesfelderCharles Swanton Brief Report 07 October 2014 Pages: 221 - 229
Response to the article by Evangelista et al.: Use of a portable gamma camera for guiding surgical treatment in locally advanced breast cancer in a post-neoadjuvant therapy setting. Breast Cancer Res Treat 2014 Alexandre BricouEmmanuel Barranger Letter to the Editor 25 July 2014 Pages: 231 - 232